Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1994;138(1):117–134. doi: 10.1007/BF01310043

The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens

J Ignjatovic 1, L Galli 1
PMCID: PMC7087189  PMID: 7980002

Summary

The S1, N and M proteins, obtained from the nephropathogenic N1/62 strain of infectious bronchitis virus (IBV) by immunoaffinity purification with monoclonal antibodies, were used for immunization of chickens. For all three antigens multiple immunizations were necessary for induction of an antibody response. Protection of chickens vaccinated with the S1 glycoprotein against virulent challenge was demonstrated by the complete absence of virus in tracheas and kidneys of vaccinated chickens. Following four immunizations with the S1 glycoprotein 71% and 86% of chickens were protected at the level of tracheas and kidneys, respectively. Three immunizations with the S1 glycoprotein protected 70% and 10% of chickens at the level of kidney and trachea, respectively. Neither the N nor the M antigen induced protection to a virulent challenge with the nephropathogenic N1/62 strain of IBV after four immunizations. Virus neutralizing, haemagglutination inhibiting and ELISA antibodies were detected in chickens immunized with the S1 glycoprotein and inactivated N1/62 virus, however there was no correlation between the presence of any of these antibodies and protection.

Keywords: Monoclonal Antibody, Infectious Disease, Antibody Response, Bronchitis, Haemagglutination Inhibit

References

  • 1.Barthold SW, Smith AL. Virus strain specificity of challenge immunity to coronavirus. Arch Virol. 1989;104:187–196. doi: 10.1007/BF01315542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Boots AMH, Kusters JG, Van Noort JM, Zwaagstra KA, Rijke E, Van Der Zeijst BAM, Hensen EJ. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology. 1991;74:8–13. [PMC free article] [PubMed] [Google Scholar]
  • 3.Boots AMH, Benaissa-Trouw BJ, Hesselink W, Rijke E, Schrier C, Hensen EJ. Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein. Vaccine. 1992;10:119–124. doi: 10.1016/0264-410X(92)90028-I. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boursnell MEG, Binns MM, Foulds IJ, Brown TDK. Sequences of the nucleocapsid genes from two strains of avian infectious bronchitis virus. J Gen Virol. 1985;66:573–580. doi: 10.1099/0022-1317-66-3-573. [DOI] [PubMed] [Google Scholar]
  • 5.Cavanagh D. Coronavirus IBV glycopolypeptides: size of their polypeptide moieties and nature of their oligosaccharides. J Gen Virol. 1983;64:1187–1191. doi: 10.1099/0022-1317-64-5-1187. [DOI] [PubMed] [Google Scholar]
  • 6.Cavanagh D. Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. J Gen Virol. 1983;64:1787–1791. doi: 10.1099/0022-1317-64-8-1787. [DOI] [PubMed] [Google Scholar]
  • 7.Cavanagh D. Coronavirus IBV: structural characterization of the spike protein. J Gen Virol. 1983;64:2577–2583. doi: 10.1099/0022-1317-64-12-2577. [DOI] [PubMed] [Google Scholar]
  • 8.Cavanagh D, Darbyshire JH, Davis P, Peters RW. Induction of humoral neutralising and haemagglutination-inhibiting antibody by the spike protein of avian infectious bronchitis virus. Avian Pathol. 1984;13:573–583. doi: 10.1080/03079458408418556. [DOI] [PubMed] [Google Scholar]
  • 9.Cavanagh D, Davis PJ, Darbyshire JH, Peters RW. Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol. 1986;67:1435–1442. doi: 10.1099/0022-1317-67-7-1435. [DOI] [PubMed] [Google Scholar]
  • 10.Cook JKA, Davison TF, Huggins MB, Mclaughlan P. Effect of in ovo bursectomy on the course of an infectious bronchitis virus infection in line C White Leghorn chickens. Arch Virol. 1991;118:225–234. doi: 10.1007/BF01314032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Daniel C, Talbot PJ. Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology. 1990;174:87–94. doi: 10.1016/0042-6822(90)90057-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Darbyshire JH, Rowell JG, Cook JKA, Peters RW. Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Arch Virol. 1979;61:227–238. doi: 10.1007/BF01318057. [DOI] [PubMed] [Google Scholar]
  • 13.De Diego M, Laviada MD, Ehjuanes L, Escribano JM. Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus. J Virol. 1992;66:6502–6508. doi: 10.1128/jvi.66.11.6502-6508.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.De Groot RJ, Van Leen RW, Dalderup MJM, Vennema H, Horzinek MC, Spann WJM. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology. 1989;171:493–502. doi: 10.1016/0042-6822(89)90619-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hasony HJ, Macnaughton MR. Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice. Arch Virol. 1981;69:33–41. doi: 10.1007/BF01315263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Homberger FR, Barthold SW. Passively aquired challenge immunity to enterotropic coronavirus in mice. Arch Virol. 1992;126:35–43. doi: 10.1007/BF01309682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ignjatovic J, Mcwaters PG. Monoclonal antibodies to three structural proteins of avian infectious bronchitis virus: characterization of epitopes and antigenic differentiation of Australian strains. J Gen Virol. 1991;72:2915–2922. doi: 10.1099/0022-1317-72-12-2915. [DOI] [PubMed] [Google Scholar]
  • 19.King DJ, Cavanagh D. Infectious bronchitis. In: Calnek BW, Barnes HJ, Beard CW, Reid WM, Yoder HW Jr, editors. Diseases of poultry. 9th edn. Ames: Iowa State University Press; 1991. pp. 471–484. [Google Scholar]
  • 20.Koch G, Hartog L, Kant A, Van Roozelaar DJ. Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions. J Gen Virol. 1990;71:1929–1935. doi: 10.1099/0022-1317-71-9-1929. [DOI] [PubMed] [Google Scholar]
  • 21.Koolen MJM, Borst MAJ, Horzinek MC, Spaan WJM. Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol. 1990;64:6270–6273. doi: 10.1128/jvi.64.12.6270-6273.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kusters JG, Jager EJ, Niesters HGM, Van Der Zeijst BAM. Sequence evidence of RNA recombination in field isolates of avian coronavirus infectious bronchitis virus. Vaccine. 1990;8:605–608. doi: 10.1016/0264-410X(90)90018-H. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kusters JG, Jager EJ, Lenstra JA, Koch G, Posthumus WPA, Meloen RH, Van Der Zeijst BAM. Analysis of an immunodominant region of infectious bronchitis virus. J Immunol. 1989;143:2692–2698. [PubMed] [Google Scholar]
  • 24.Lenstra JA, Kusters JG, Koch G, Van Der Zeijst BAM. Antigenicity of the peplomer protein of infectious bronchitis virus. Mol Immunol. 1989;26:7–15. doi: 10.1016/0161-5890(89)90014-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mobley J, Evans G, Dailey MO, Perlman S. Immune response to a murine coronavirus: identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins. Virology. 1992;187:443–452. doi: 10.1016/0042-6822(92)90446-V. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mockett APA. Envelope proteins of avian infectious bronchitis virus: purification and biological properties. J Virol Methods. 1985;12:271–278. doi: 10.1016/0166-0934(85)90138-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mockett APA, Cavanagh D, Brown TDK. Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41. J Gen Virol. 1984;65:2281–2286. doi: 10.1099/0022-1317-65-12-2281. [DOI] [PubMed] [Google Scholar]
  • 28.Perlman S, Schelper R, Ries D. Maternal antibody-modulated MHV-JHM infection in C57BL/6 and Balb/c mice. Adv Exp Med Biol. 1987;218:297–305. doi: 10.1007/978-1-4684-1280-2_39. [DOI] [PubMed] [Google Scholar]
  • 29.Spaan WJM. Progress towards a coronavirus recombinant DNA vaccine. In: Cavanagh D, Brown TDK, editors. Coronaviruses and their diseases. New York: Plenum Press; 1990. pp. 201–203. [Google Scholar]
  • 30.Sturman LS, Ricard CS, Holmes KV. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90 K cleavage fragments. J Virol. 1985;56:904–911. doi: 10.1128/jvi.56.3.904-911.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sussman MA, Shubin RA, Kyuwa S, Stohlman SA. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol. 1989;63:3051–3056. doi: 10.1128/jvi.63.7.3051-3056.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Talbot PJ, Dionne G, Lacroix M. Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol. 1988;62:3032–3036. doi: 10.1128/jvi.62.8.3032-3036.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vennema H, De Groot RJ, Harbour DA, Dalderup M, Gruffydd-Jones T, Horzinek MC, Spaan WJM. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol. 1990;64:1407–1409. doi: 10.1128/jvi.64.3.1407-1409.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Vennema H, De Groot RJ, Harbour DA, Horzinek MC, Spaan WJM. Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology. 1991;181:327–335. doi: 10.1016/0042-6822(91)90499-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wang L, Junker D, Collisson EW. Evidence of natural recombination within the S1 gene of infectious bronchitis virus. Virology. 1993;192:710–716. doi: 10.1006/viro.1993.1093. [DOI] [PubMed] [Google Scholar]
  • 36.Wesseling JG, Godeke G-J, Schijns VECJ, Prevec L, Graham FL, Horzinek MC, Rottier PJM. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J Gen Virol. 1993;74:2061–2069. doi: 10.1099/0022-1317-74-10-2061. [DOI] [PubMed] [Google Scholar]
  • 37.Yamaguchi K, Goti N, Kyuwa S, Hayami M, Toyoda Y. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol. 1991;32:1–9. doi: 10.1016/0165-5728(91)90065-F. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES

OSZAR »